DiaMedica Therapeutics Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
DiaMedica Therapeutics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q4 2018 to Q2 2024.
  • DiaMedica Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending June 30, 2024 was $119K, a 2.59% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $119K +$3K +2.59% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $119K +$3K +2.59% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $116K Dec 31, 2023 10-K 2024-03-19
Q3 2023 $116K +$3K +2.66% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $116K Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $116K Mar 31, 2023 10-Q 2023-05-15
Q3 2022 $113K Sep 30, 2022 10-K 2023-03-28
Q1 2020 $46K -$22K -32.4% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $46K -$22K -32.4% Dec 31, 2019 10-K 2020-03-23
Q3 2019 $68K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $68K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $68K Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $68K Dec 31, 2018 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.